Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004
Internuclear Ophthalmoplegia as an Isolated or Predominant Symptom of Brainstem Infarction
Neurol 62:1491-1496, Kim,J.S., 2004
Neurologic Manifestations of Kanzaki Disease
Neurol 62:1604-1606, Umehara,F.,et al, 2004
Stalevo for Parkinson's Disease
The Medical Letter 46:39, , 2004
Infantile Bilateral Striatal Necrosis Maps to Chromosome 19q
Neurol 62:87-90, Basel-Vanagaite,L.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004
Warfarin, Hematoma Expansion, and Outcome of Intracerebral Hemorrhage
Neurol 63:1059-1064, Flibotte,J.J.,et al, 2004
Anticoagulants for Acute Ischemic Stroke
Stroke 35:2916-2917, Sandercock,P.,et al, 2004
Migrainous Vertigo Presenting as Episodic Positional Vertigo
Neurol 62:469-472, vonBrevern,M.,et al, 2004
Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003
Anticoagulation or Inferior Vena Cava Filter Placement for Patients with Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Stroke 34:2999-3005, Kelly,J.,et al, 2003
Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003
Drug Treatments for Eye Movement Disorders
JNNP 74:1-4, Leigh,R.J., &Tomsak,R.L., 2003
Vestibular Neuritis
NEJM 348:1027-1032, Baloh,R.W., 2003
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Nodulus Infarction Mimicking Acute Peripheral Vestibulopathy
Neurol 60:1700-1702, Lee,H.,et al, 2003
Oral Anticoagulation in Patients After Cerebral Ischemia of Arterial Origin and Risk of Intracranial Hemorrhage
Stroke 34:e45, ESPRIT, 2003
Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
Stroke 34:1339-1345, Avierinos,J.,et al, 2003
Clinicopath Conf., Giant-Cell Arteritis
NEJM 349:170-180, Case 21-2003, 2003
Can Patients be Anticoagulated After Intracerebral Hemorrhage?
Stroke 34:1710-1716, Eckman,M.H.,et al, 2003
A Risk Score for Predicting Stroke or Death in Individuals with New-Onset Atrial Fibrillation in the Community
JAMA 290:1049-1056,1093, Wang,T.J.,et al, 2003
Stroke Prevention in Atrial Fibrillation
JAMA 290:1093-1095, Waldo,A.L., 2003
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
NEJM 349:1019-1026, Hylek,E.M.,et al, 2003
Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003
Stroke Risk in Anticoagulated Patients with Atrial Fibrillation Undergoing Endoscopy
Neurol 61:964-968, Blacker,D.J.,et al, 2003
Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Arch Int Med 163:901-908, Dunn,A.S. &Turpie,A.G.G., 2003
Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002
Epileptic Monocular Nystagmus
Neurol 59:1438-1441, Grant,A.C.,et al, 2002
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002
Herpes Zoster Vasculitis Presenting as Giant Cell Arteritis with Bilateral Internuclear Ophthalmoplegia
AJO 134:912-914, Al-Abdulla,N.A.,et al, 2002
Clinical Profile of Stroke in 900 Patients with Hypertrophic Cardiomyopathy
J Am Coll Cardiol 39:301-307, Maron,B.J.,et al, 2002
Positional Down Beating Nystagmus in 50 Patients: Cerebellar Disorders and Possible Anterior Semicircular Canalithiasis
JNNP 72:366-372, Bertholon,P.,et al, 2002
Clinicopath Conf, Primary Lymphoma of CNS
NEJM 346:1009-1015, Case 10-2002, 2002
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002
Leukoaraiosis is Associated with Warfarin-Related Hemorrhage Following Ischemic Stroke
Neurol 59:193-197, Smith,E.E.,et al, 2002
New Evidence for Stroke Prevention
JAMA 288:1396-1398, Straus,S.E.,et al, 2002
New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002
Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001
MRI Characteristics of the MLF in MS Patients with Chronic Internuclear Ophthalmoparesis
Neurol 57:762-768, Frohman,E.M.,et al, 2001
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
Cystic Fibrosis Presenting With Intracerebral Haemorrhage
Lancet 358:1960, Merelle,M.E.,et al, 2001
Oral Anticoagulation for Cerebral Ischemic of Arterial Origin
Neurol 57:1993-1999, Torn,M.,et al, 2001
Clinicopath Conf, Traumatic Perilymphatic Fistula, Bacterial Labyrinthitis, Meningitis Due to Streptococcus Pneumoiae
NEJM 345:1901-1907, Case 40-2001, 2001